Kollmar R, Schwab S
Neurologische Abteilung der Friedrich-Alexander Universität Erlangen-Nürnberg.
Dtsch Med Wochenschr. 2010 Nov;135(47):2361-5. doi: 10.1055/s-0030-1267524. Epub 2010 Nov 16.
Therapeutic hypothermia (TH) is very effective for the treatment of acute experimental brain injury. In contrast to other neuroprotective methods or pharmacological agents, TH represents the only clinically proven neuroprotective therapy. TH led to a decreased mortality rate and improved functional outcome in patients with cardiac arrest. Investigations in severe head trauma are inconclusive up to now. Other important indications such as ischemic stroke remain to be investigated properly. Recent phase II studies are on the way to test safety and feasibility in the early time window of stroke including thrombolysis. The recent article describes the status and perspectives including open questions for hypothermia in neurological intensive care.
治疗性低温(TH)对急性实验性脑损伤的治疗非常有效。与其他神经保护方法或药物不同,TH是唯一经临床验证的神经保护疗法。TH可降低心脏骤停患者的死亡率并改善功能预后。迄今为止,对重度颅脑外伤的研究尚无定论。其他重要适应症如缺血性中风仍有待进行充分研究。近期的II期研究正在对包括溶栓在内的中风早期时间窗内的安全性和可行性进行测试。最近的这篇文章描述了神经重症监护中低温治疗的现状、前景以及存在的未决问题。